Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,390 | 71,643 | 28,575 | 11,639 | 27,593 |
| Marketable Securities | 58,588 | 34,827 | 23,528 | 32,062 | 23,896 |
| Other current assets | 959 | 410 | 1,029 | 253 | 165 |
| TOTAL | $87,937 | $106,880 | $53,132 | $43,954 | $51,654 |
| Non-Current Assets | |||||
| PPE Net | 7,840 | 8,472 | 7,727 | 6,901 | 4,966 |
| Other Non-Current Assets | 3,204 | 823 | 133 | 188 | 464 |
| TOTAL | $11,044 | $9,295 | $7,860 | $7,089 | $5,430 |
| Total Assets | $98,981 | $116,175 | $60,992 | $51,043 | $57,084 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,022 | 1,398 | 3,478 | 678 | 755 |
| Accrued Expenses | 3,503 | 2,272 | 1,166 | 1,055 | 526 |
| Other current liabilities | 197 | 635 | 854 | 292 | 271 |
| TOTAL | $8,797 | $5,968 | $7,264 | $3,855 | $2,735 |
| Non-Current Liabilities | |||||
| TOTAL | $4,912 | $4,729 | $4,208 | $3,338 | $2,142 |
| Total Liabilities | $13,709 | $10,697 | $11,472 | $7,193 | $4,877 |
| Shareholders' Equity | |||||
| Common Shares | 173 | 172 | 125 | 122 | 118 |
| Retained earnings | -56,939 | -35,411 | -17,816 | -19,853 | -11,367 |
| Other shareholders' equity | 0 | -203 | 0 | 0 | 0 |
| TOTAL | $85,272 | $105,478 | $49,520 | $43,850 | $52,207 |
| Total Liabilities And Equity | $98,981 | $116,175 | $60,992 | $51,043 | $57,084 |